Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · Real-Time Price · USD
22.21
-1.04 (-4.47%)
Oct 22, 2025, 4:00 PM EDT - Market closed
Spyre Therapeutics Market Cap
Spyre Therapeutics has a market cap or net worth of $1.34 billion as of October 23, 2025. Its market cap has decreased by -3.96% in one year.
Market Cap
1.34B
Enterprise Value
814.93M
1-Year Change
-3.96%
Ranking
Category
Stock Price
$22.21
Market Cap Chart
Since April 7, 2016, Spyre Therapeutics's market cap has increased from $111.70M to $1.34B, an increase of 1,100.99%. That is a compound annual growth rate of 29.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2025 | 1.34B | 12.04% |
| Dec 31, 2024 | 1.20B | 1,274.63% |
| Dec 29, 2023 | 87.10M | 214.44% |
| Dec 30, 2022 | 27.70M | -88.18% |
| Dec 31, 2021 | 234.30M | -37.90% |
| Dec 31, 2020 | 377.30M | 70.42% |
| Dec 31, 2019 | 221.40M | 23.34% |
| Dec 31, 2018 | 179.50M | 99.44% |
| Dec 29, 2017 | 90.00M | 54.11% |
| Dec 30, 2016 | 58.40M | -47.72% |
| Apr 7, 2016 | 111.70M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 729.35B |
| Johnson & Johnson | 464.66B |
| AbbVie | 403.98B |
| UnitedHealth Group | 327.39B |
| AstraZeneca | 259.95B |
| Novartis AG | 255.24B |
| Novo Nordisk | 237.27B |
| Abbott Laboratories | 222.69B |